RNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins?

F Fabbiano, J Corsi, E Gurrieri… - Journal of …, 2020 - Wiley Online Library
Extracellular vesicles (EVs) are heterogeneous membranous particles released from the
cells through different biogenetic and secretory mechanisms. We now conceive EVs as …

[HTML][HTML] MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer

G Bertoli, C Cava, I Castiglioni - Theranostics, 2015 - ncbi.nlm.nih.gov
Dysregulation of microRNAs (miRNAs) is involved in the initiation and progression of
several human cancers, including breast cancer (BC), as strong evidence has been found …

G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms

PJ Bates, EM Reyes-Reyes, MT Malik… - … et Biophysica Acta (BBA …, 2017 - Elsevier
Background AS1411 is a 26-mer G-rich DNA oligonucleotide that forms a variety of G-
quadruplex structures. It was identified based on its cancer-selective antiproliferative activity …

New perspectives of physiological and pathological functions of nucleolin (NCL)

W Jia, Z Yao, J Zhao, Q Guan, L Gao - Life sciences, 2017 - Elsevier
Nucleolin (NCL) is a multifunctional protein that mainly localized in the nucleolus, it is also
found in the nucleoplasm, cytoplasm and cell membrane. The three main structural domains …

Inducible degradation of oncogenic nucleolin using an aptamer-based PROTAC

M Chen, P Zhou, Y Kong, J Li, Y Li… - Journal of Medicinal …, 2023 - ACS Publications
While proteolysis-targeting chimeras (PROTACs) are showing promise for targeting
previously undruggable molecules, their application has been limited by difficulties in …

The roles of nucleolin subcellular localization in cancer

CM Berger, X Gaume, P Bouvet - Biochimie, 2015 - Elsevier
Nucleolin (NCL) is one of the most abundant non ribosomal protein of the nucleolus where it
plays a central role in polymerase I transcription. NCL is also found outside of the nucleolus …

Molecularly engineering triptolide with aptamers for high specificity and cytotoxicity for triple-negative breast cancer

J He, T Peng, Y Peng, L Ai, Z Deng… - Journal of the …, 2020 - ACS Publications
Triple-negative breast cancer (TNBC) lacks three important receptors, ER, PR, and HER2. It
is more aggressive and more likely to relapse after treatment, thus has been identified as …

Potential value of miR-221/222 as diagnostic, prognostic, and therapeutic biomarkers for diseases

J Song, Y Ouyang, J Che, X Li, Y Zhao, K Yang… - Frontiers in …, 2017 - frontiersin.org
microRNAs (miRNAs) are short non-coding RNAs that regulate gene expression by base
pairing with their target messenger RNAs. Dysregulation of miRNAs is involved in the …

Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes

S Kurozumi, Y Yamaguchi, M Kurosumi… - Journal of human …, 2017 - nature.com
MicroRNAs (miRNAs) are short non-coding RNAs that regulate the function of target genes
at the post-transcriptional phase. miRNAs are considered to have roles in the development …

MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance, and applications in human triple-negative breast cancer

L Ding, H Gu, X Xiong, H Ao, J Cao, W Lin, M Yu, J Lin… - Cells, 2019 - mdpi.com
Triple-negative breast cancer (TNBC) is the most aggressive, prevalent, and distinct subtype
of breast cancer characterized by high recurrence rates and poor clinical prognosis, devoid …